Trial Profile
The Vascular Protective Effect of Aliskiren- or Ramipril-Based Treatment in Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Ramipril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 13 May 2012 New trial record
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.